Harold Wheatley, MD
Retina Specialist · New Brunswick, NJNPI 1154394963
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $11,645 of the $12,536 with a category attached, or 92.9%. Carl Zeiss Meditec, Inc. accounts for 93.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $9,538 and has fallen 97.8% since, to $212 in 2025.
Across 28 payments — averaging $447.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$12K
- Alcon$281
- AbbVie$215
- Regeneron Healthcare Solutions, Inc.$198
- Sandoz$24
- Bausch & Lomb Americas Inc.$23
- plus $81 from 5 others
Across 18 payments — averaging $4143.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$75K
What the payments were for
- Food & beverage$8927%
- Gifts$11,64593%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 4 | $11,714 |
| Alcon | 2 | $281 |
| AbbVie | 9 | $215 |
| Regeneron Healthcare Solutions, Inc. | 6 | $198 |
| Sandoz | 1 | $24 |
| Bausch & Lomb Americas Inc. | 1 | $23 |
| Apellis Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Alimera Sciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CLARUS$9,538
- CLARUS 500 Fundus Camera$2,107
- NGENUITY$281
- Constellation$281
- EYLEA$122
How this compares
$12,536 in reported general payments places this provider in the 75th percentile of 35 retina specialist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 15 | $8,752 |
| Bromfenac Sodium | 34 | $4,811 |
| Prednisolone Acetate | 52 | $2,411 |
| Ketorolac Tromethamine | 67 | $2,213 |
| Timolol Maleate | 46 | $544 |
| Dorzolamide Hcl | 22 | $401 |
| ValacyclovirValacyclovir Hcl | 15 | $290 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 28 | $236 |
| Brimonidine Tartrate | 18 | $230 |
| Latanoprost | 54 | $194 |
| Diclofenac Sodium | 11 | $125 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in New Brunswick
- Howard FineNew Brunswick$955K
- Jonathan PrennerNew Brunswick$215K
- Daniel RothNew Brunswick$61K
- Sumit ShahNew Brunswick$41K
- Bruce KeyserNew Brunswick$8K
- Eric FriedmanNew Brunswick$554
- Stuart GreenNew Brunswick$22
- Joshua MaliFlemington$230K
- Leonard FeinerUnion$72K
- Vatsal DoshiMillburn$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.